93
Views
12
CrossRef citations to date
0
Altmetric
Review

The epidermal growth factor receptor family in breast cancer

&
Pages 5-19 | Published online: 14 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Cobra Moradian & Fatemeh Rahbarizadeh. (2019) Targeted Toxin Gene Therapy Of Breast Cancer Stem Cells Using CXCR1 Promoter And bFGF 5′UTR. OncoTargets and Therapy 12, pages 8809-8820.
Read now
Gunjan Vasant Bonde, Sarita Kumari Yadav, Sheetal Chauhan, Pooja Mittal, Gufran Ajmal, Sathish Thokala & Brahmeshwar Mishra. (2018) Lapatinib nano-delivery systems: a promising future for breast cancer treatment. Expert Opinion on Drug Delivery 15:5, pages 495-507.
Read now

Articles from other publishers (10)

M. Kopec & H. Abramczyk. (2022) The role of pro- and antiangiogenic factors in angiogenesis process by Raman spectroscopy. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 268, pages 120667.
Crossref
Nasim Vahidfar, Ayuob Aghanejad, Hojjat Ahmadzadehfar, Saeed Farzanehfar & Elisabeth Eppard. (2021) Theranostic Advances in Breast Cancer in Nuclear Medicine. International Journal of Molecular Sciences 22:9, pages 4597.
Crossref
Mie A. Nordmaj, Morgan E. Roberts, Emilie S. Sachse, Robert Dagil, Anne Poder Andersen, Nanna Skeltved, Kaare V. Grunddal, Sayit Mahmut Erdoğan, Swati Choudhary, Tobias Gustsavsson, Maj Sofie Ørum-Madsen, Igor Moskalev, Weihua Tian, Zhang Yang, Thomas M. Clausen, Thor G. Theander, Mads Daugaard, Morten A. Nielsen & Ali Salanti. (2021) Development of a bispecific immune engager using a recombinant malaria protein. Cell Death & Disease 12:4.
Crossref
Sounak Sadhukhan & S. K. Basu. (2020) Avascular tumour growth models based on anomalous diffusion. Journal of Biological Physics 46:1, pages 67-94.
Crossref
N. Sekhon, R.A. Kumbla & M. Mita. 2017. Cardio-Oncology. Cardio-Oncology 1 24 .
Bhavya Balan Chandrika, Mathew Steephan, T.R. Santhosh Kumar, A. Sabu & M. Haridas. (2016) Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors. Life Sciences 160, pages 47-56.
Crossref
Rajesh, Zhaoli Gao, Ramya Vishnubhotla, Pedro Ducos, Madeline Díaz Serrano, Jinglei Ping, Matthew K. Robinson & Alan Thornton Charlie Johnson. (2016) Genetically Engineered Antibody Functionalized Platinum Nanoparticles Modified CVD‐Graphene Nanohybrid Transistor for the Detection of Breast Cancer Biomarker, HER3. Advanced Materials Interfaces 3:17, pages 1600124.
Crossref
Stephan Lindsey & Sigrid A. Langhans. 2015. 1 41 .
Münteha Nur Sonuç & Mustafa Kemal Sezgintürk. (2014) Ultrasensitive electrochemical detection of cancer associated biomarker HER3 based on anti-HER3 biosensor. Talanta 120, pages 355-361.
Crossref
Angelos K. Koutras, George Fountzilas, Konstantine T. Kalogeras, Ioannis Starakis, Gregoris Iconomou & Haralabos P. Kalofonos. (2010) The upgraded role of HER3 and HER4 receptors in breast cancer. Critical Reviews in Oncology/Hematology 74:2, pages 73-78.
Crossref